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Abstract  
Bacterial vaginosis (BV) is the worldwide leading vaginal disorder in women of reproductive age. BV is 
characterized by the replacement of beneficial lactobacilli and the augmentation of anaerobic bacteria. 
Gardnerella vaginalis is a predominant bacterial species, however, BV is also associated with other 
numerous anaerobes, such as Atopobium vaginae, Mobiluncus mulieris, Prevotella bivia, Fusobacterium 
nucleatum and Peptoniphilus sp.. Currently, the role of G. vaginalis in the etiology of BV remains a matter 
of controversy. It is however known that, in BV patients, a biofilm is usually formed on the vaginal 
epithelium and G. vaginalis is typically the predominant species. So, the current paradigm is that the 
establishment of a biofilm plays a key role in the pathogenesis of BV. This review provides background on 
the influence of biofilm formation by G. vaginalis and other anaerobes in the polymicrobial etiology of BV, 
through its initial adhesion until biofilm formation and discusses the commensal and synergic interactions 
established between them to understand the phenotypic shift of G. vaginalis’ biofilms into BV 
establishment. 
 




Etiology of bacterial vaginosis  
Bacterial vaginosis (BV) is the most common vaginal disorder in women of reproductive age and 
the cause of several symptoms, such as homogeneous malodorous vaginal discharge, overgrowth of 
anaerobes and increased production of amines (putrescines, cadaverines and trimethylamine) that 
contribute to a higher vaginal pH and presence of clue cells (1). BV is responsible for more than 60% of 
vulvovaginal infections and has been linked to serious public health consequences including pelvic 
inflammatory disease (2), postoperative infections (3), acquisition and transmission of the human 
immunodeficiency virus (HIV) (4), preterm birth and several adverse outcomes in pregnancy (5).  
The healthy vaginal epithelium is generally dominated by hydrogen peroxide and lactic acid 
producing lactobacilli (6), acting as a protective surfactant layer that leads to an acidic pH (7) that inhibits 
the adhesion and the growth of other bacteria, including opportunistic pathogens on the vaginal 
epithelium (8). During the development of BV, the normal vaginal microbiota composition changes and it 
is characterized by a decrease in these lactobacilli species and an increase in the numbers of several 
pathogenic bacteria, mainly anaerobes (9). Currently, the initial steps in this microbial shift are still a 
matter of debate and two main theories try to explain the events leading to BV. Some evidence points to 
the fact that certain anaerobes are capable of acting as primary pathogens in the vaginal microbiota and 
displace the protective lactobacilli layer (6), but there are also claims that the anaerobe overgrowth could 





The lack of basic information about the etiology of BV has led to an ongoing debate between two 
main hypotheses, known as the polymicrobial and the single pathogen hypotheses. The single 
pathogenic agent hypothesis defends that a single pathogenic species is responsible to induce the 
microbial switch and to cause BV (11). The polymicrobial hypothesis assumes that BV is caused by a 
mixture of anaerobic pathogenic bacteria. This hypothesis is strongly supported by the fact that multiple 
bacteria are often found in BV (12) and recently culture-independent methods showed that this 
polymicrobial community may be even more complex than previously thought (13). However, the 
presence of a bacterium in BV has been rarely supported by microbiological functional studies, 
demonstrating the virulence of such species. Furthermore, epidemiological data gathered in multiple 
studies suggest a sexual transmission role in BV and raises doubts to the polymicrobial causative nature 
of BV (14).   
 
Anaerobes involved in bacterial vaginosis 
 Although current knowledge about BV etiology remains scarce, the common consensus is that 
BV is always associated with the overgrowth of numerous bacterial species. As reviewed by Livengood, 
conventional medium cultivation of the vaginal microbiota from BV women identified a typical spectrum of 
anaerobes, including Gardnerella vaginalis, Atopobium vaginae, Mobiluncus mulieris, Prevotella bivia, 
Fusobacterium nucleatum, Ureaplasma urealyticum and Mycoplasma hominis (15). With the advances in 
culture-independent molecular techniques, BV spectrum of anaerobes was greatly expand adding 
Eggerthella, Megasphaera, Leptotrichia, Dialister, Bifidobacterium, Slackia and other bacteria related to 
Arthrobacter, Caulobacter and Butyrivibrio (12). Also, the Vaginal Human Microbiome Project has 
detected several newly described bacteria in the Clostridiales order that are currently designated BVAB1, 
BVAB2, and BVAB3 (16). Interestingly, differences in the BV vaginal microbiome between American 
women and women of European ancestry were found being American women more likely to be colonized 
by Anaerococcus tetradius, BVAB1, BVAB3, Coriobacteriaceae, Sneathia, Parvimonas, Dialister, 
Megasphera, Bulleidia, Prevotella and Atopobium species; while women of European ancestry were more 
likely colonized by M. hominis, Dialister micraerophilus and Gemella species (16). Despite of this likely 
secondary anaerobic colonizer diversity in women with different ancestry and geographical localization, 
G. vaginalis remains a central bacteria species in the BV vaginal microbiome.  
 It has been hypothesized that the establishment of a biofilm plays a key role in the pathogenesis 
of BV (17). Swidsinski and colleagues have demonstrated that a biofilm was present in 90% of the 
epithelial surfaces from BV vaginal biopsy specimens, being G. vaginalis the major component of these 
multispecies communities (9). The role of biofilms in BV is also supported by the work of Patterson and 
colleagues, which demonstrated that G. vaginalis biofilms exhibited higher tolerance to hydrogen 
peroxide and lactic acid, when compared to planktonic cells. They suggested that the biofilm increased 
resistance against lactobacilli probiotic properties would present an advantage for G. vaginalis growth in 
biofilms (18). On a follow up study, O'Hanlon and colleagues confirmed the bactericidal potential of lactic 
acid in BV-associated bacteria (19) although providing evidence that the role of hydrogen peroxide is 
minor due to its interactions with vaginal fluid and semen (20).  Patterson and colleagues also showed 
that, when compared with A. vaginae, M. mulieris, P. bivia and Peptoniphilus sp., G. vaginalis was the 
only anaerobe to exhibit three key virulence determinants in BV, more exactly, adherence to vaginal 
epithelial cells, biofilm-producing capacity and cytotoxic activity (21). These findings were recently 
confirmed by Alves and colleagues, where they tested G. vaginalis virulence against other 29 bacteria 
species associated with BV, such as M. hominis, Corynebacterium tuscaniense, Aerococcus 
christensenii, Gemella haemolysins and Mycoplasma hominis (22). Hence, all these findings suggest that 
biofilm forming G. vaginalis plays a key role in BV pathogenesis.  
 
G. vaginalis biofilm formation and BV establishment  
 Generally, the biofilm life-cycle includes 3 main stages: initial adhesion, accumulation and 
dispersal (Figure 1A). Therefore, the initial adhesion to the vagina epithelium is a crucial step for the 
development of BV biofilms. It was postulated that G. vaginalis requires the help of others anaerobes to 
start BV development (23). Earlier studies by Mardh and colleagues tested the ability of multispecies 









Figure 1 | Conceptual monospecies and multispecies models about the development of biofilm formation. 
(A) Conceptual monospecies biofilm lifecycle: when the environmental conditions are appropriate, 
planktonic cells will adhere to a surface and grow into a multi-layer structure composed of bacteria and 
extracellular components. Eventually, bacteria will detach from the biofilm and the resulting cells will be 
able to restart the biofilm cycle in a different location. (B) Polymicrobial biofilms, such as in BV, secondary 
bacteria will incorporate the biofilm after the initial colonizer species has already adhered to the surface. 
Synergetic relationship can then be formed, allowing the biofilm to prosper. 
 
However, at that time, the association of biofilms with BV was unknown and these researchers were not 
able to explore the biofilm phenotype in BV development. With the studies of Swidsinski and colleagues, 
clue cells were finally understood as biofilm-coated epithelial cells desquamated from the epithelial 
surface (9). Although the biofilm was shown to contain high concentrations of a variety of bacterial 
groups, G. vaginalis was found to be the predominant constituent. Many follow up studies validated their 
findings (25,26) and it’s now accepted that biofilms in BV are strongly associated with G. vaginalis (17). 
Using a novel multiplex PNA-FISH approach (27), it was recently showed that G. vaginalis was able to 





associated anaerobes, such as A. vaginae, M. mulieres, P. bivia and F. nucleatum, revealed to be less 
virulent (28). Although other tested anaerobes were also able to adhere in high numbers, such as A. 
vaginae and M. mulieris, they were easily outcompeted by L. crispatus (28). Those results suggest that G. 
vaginalis plays a central role in the early adhesion stages that could lead to the formation of clue cell, as 
previously postulated by Swidsinski and Patterson (17,21). This new evidence raises an interesting 
question: can the overall community of bacteria found in BV mixed species biofilms be mainly composed 
by opportunistic secondary colonizers? Interestingly, Swidsinski and colleagues demonstrated that G. 
vaginalis was able to incorporate other bacterial groups into its biofilms (17). Later, Alves and colleagues 
demonstrated that more than 20 BV associated species showed a natural tendency to grown as biofilms, 
despite they are apparently unable to establish a primary biofilm in the vaginal epithelium (22). 
 
Bacterial interaction in multispecies BV biofilms 
Despite the growing evidence that G. vaginalis has an higher virulence potential than any other 
BV associated bacteria tested so far, an enduring enigma is whether G. vaginalis alone is capable of 
causing BV or whether G. vaginalis needs the interaction with others anaerobic species. Interestingly, 
with the advancement of molecular techniques, it has been shown that G. vaginalis is capable to establish 
different interactions with other BV-associated anaerobes (29,30). It was recently demonstrated that a 
pre-formed G. vaginalis biofilms was able to establish symbiotic relationship with other BV associated 
anaerobes. Regardless of the secondary species, G. vaginalis biofilm growth was promoted by the 
presence of the additional species. This effect was more prominent in the presence of P. bivia and M. 
mulieris, but all tested BV-associated anaerobes were able to enhance G. vaginalis growth (30). 
Furthermore, Datcu and colleagues have shown that amino acids produced by G. vaginalis may promote 
the growth of P. bivia and F. nucleatum (29). In a study on multispecies oral biofilms, Foster and 
Kolenbrander (31) demonstrated that F. nucleatum was capable of co-aggregating with pathogenic 
bacteria and becoming a dominant member of the oral multispecies biofilm after several days of 
incubation. However, F. nucleatum commonly failed to grow by itself in biofilms. Interestingly, F. 
nucleatum was shown to be able to join an initial biofilm and eventually establishes a symbiotic 
relationship with G. vaginalis (30). It is well-known that F. nucleatum expresses receptors that adhere to a 
large variety of other bacterial species, acting as intermediate colonizer between early and late colonizers 
(32).  
Other studies that highlight the benefits for synergistic relationships in BV development have 
been reported. A. vaginae is commonly isolated from cases of BV (9) and has been associated with its 
potential to induce an inflammatory response during late stage of BV. However, alone, this bacterium did 
not demonstrate any specific virulence factors (33). It has also been described that, during BV, 
Mobiluncus species is known to produce proteolytic activity through proline aminopeptidase (34) and was 
postulated that the available peptides and aminoacids could facilitate an anaerobic growth in the vaginal 
epithelium (35). In fact, Pybus and Onderdonk directly demonstrated that these peptides are able to 
stimulates the in vitro growth of G. vaginalis and P. bivia (36). Thus, the increased availability of peptides 
by M. mulieris could act as a factor promoting the development of multispecies biofilm initiated by G. 
vaginalis during BV establishment. Furthermore, Peptoniphilus sp. had been recently associated with 
persistent cases of BV. In 2008, Marrazzo and colleagues isolated this organism from 36 % of persistent 
cases of BV (37). In addition, Patterson and colleagues demonstrated the robust adherence of 
Peptoniphilus sp. to vaginal epithelial cells but a lower biofilm formation (21), postulating that 
Peptoniphilus sp. could be an earlier colonizer but would require incorporation in the G. vaginalis biofilm 
during cases of BV. Finally, several other anaerobes had been also associated to BV microbiota, such as 
Veillonella sp. and Peptostreptococcus sp., although without demonstrating a noteworthy adhesion to 
epithelial cells, biofilm formation and cytotoxicity properties (21). It is therefore feasible that the 
overgrowth of these weak colonizers in the vagina epithelium could directly depend on G. vaginalis biofilm 
development. However, this hypothesis still needs to be experimental determined. All these data support 
the plausible role of G. vaginalis as the BV initial colonizer, enabling other BV-associated anaerobes to 
colonize the vagina after the initial biofilm development (Figure 1B). Importantly, G. vaginalis can also be 
found in healthy women, despite it is only present in lower amount in the vaginal epithelium (17). So, it 





understanding why G. vaginalis is also present in healthy women is a question that still remains to be 
answered.  
 
The dilemma of vaginal colonization by G. vaginalis in healthy women 
 In the past decades, the presence of G. vaginalis in healthy women has been contradictory to the 
role of G. vaginalis as the main pathogen on BV (38). Back in 1955, Gardner and Dukes aimed to confirm 
Koch's postulates in BV by transferring G. vaginalis into the healthy vagina but BV did not developed in 
these cases (39). However, when they transferred the vaginal discharge from a BV patient, that 
nowadays we know to contain biofilms in clue cells, BV was then observed (39). Therefore, the 
association of the biofilm phenotype to G. vaginalis mediated BV development raised an important 
question: do all G. vaginalis possess the ability to develop a biofilm? In other biofilm-associated diseases, 
it has been widely demonstrated that not all strains within the same species have the ability to grow as 
biofilms (reviewed in 40). So, it’s highly probable that not all G. vaginalis will be able to develop the BV 
associated biofilm in the woman vaginal epithelium, but this needs to be further explored. An important 
insight providing evidence that not all G. vaginalis have the same virulence potential was derived from a 
recent work by Swidsinski and colleagues. They highlighted the importance of G. vaginalis biofilms when 
they observed that only biofilm forming G. vaginalis were present in the partners of women with BV (41). 
They proposed that the mere presence of loosely adherent G. vaginalis on the vaginal epithelium was of 
lesser clinical significance and BV was sexually transmissible only in the presence of high density clusters 
of G. vaginalis. Castro and colleagues recently provided in vitro evidence that supports Swidsinski 
hypothesis (42). By comparing 7 BV and 7 non-BV isolates of G. vaginalis, they observed that only the 
BV isolates were able to adhere in high density clusters to a HeLa cell line, a condition necessary to 
foster biofilm development. 
The genetic characterization of G. vaginalis virulence properties could be a possibility to confirm 
the existence of pathogenic and non-pathogenic G. vaginalis subspecies and consequently to distinguish 
between them. Harwich and colleagues were the first to sequence the whole genomes of BV and non-BV 
G. vaginalis isolates and compared their pathogenic potential properties (43). In addition, they also 
quantified, in vitro, their cytotoxic activities, adhesion ability to epithelial cells and biofilm formation. Their 
study revealed the differences in the vly genes between the BV-associated and the non-BV strains, 
showing differences in the proteins encoded by these genes and their promoters. Also, the differences in 
cytotoxicity appeared to be related to the adherence function, in which BV-associated isolate adhered 
more noticeably to the epithelial cells than non-BV isolate (43). Finally, these two isolates also showed 
differences in biofilm forming ability related to the biofilm associated protein (BAP) family gene, such as, 
central repeat region, its number and distribution of the Rib domains (43). Meanwhile, another 
comparative genomic study between G. vaginalis strains from BV and healthy patients revealed that BV 
isolates encode numerous proteins not found in healthy isolates (44). These proteins include enzymes 
enabling mucin degradation, a trait typically correlated with BV. On a subsequent study, Jayaprakash and 
colleagues attempted to classify G. vaginalis subspecies through a phylogenetic tree of cpn60 universal 
target sequences analysis (45). This subdivision revealed the presence of 4 subgroups representing G. 
vaginalis subspecies with different extension of virulent properties, specially sialidase presence, and they 
proposed that only 1 of the 4 subgroups would be involved in BV (45). Sialidase is usually associated in 
the degradation of several key mucosal protective factors, such as mucins, as well as contributing to 
exfoliation and detachment of vaginal epithelial cells (46). All this data supported the hypothesis that 
certain G. vaginalis subspecies are unable to induce BV while other strains are suited to establish G. 
vaginalis’s biofilm and eventually to elicit BV, but this clearly needs to be further studied. So, genomic 
sequencing and bacterial interaction studies on BV initial adhesion and biofilm development are essential 
to clarify BV etiology. 
 
The contribution of in vivo models to understand BV  
Despite some earlier human studies (39,47), not many in vivo studies have been reported 
regarding BV. Many of the bacterial species associated with BV have evolved to exist only in humans and 
consequently a reliable animal model for multispecies BV development does not exist. In vivo studies are 





immune response, nutrient environment conditions, types and proportion of lactobacilli species in the 
vaginal epithelium (48). 
Recently, Gilbert and colleagues proposed a murine model for vaginal infection with G. vaginalis 
(49). However, this animal model was only tested with G. vaginalis and no further studies have been 
performed with other BV-associated anaerobes or human host-specific factors were evaluated, excepting 
for clue cell formation. Nevertheless, they were able to demonstrate an association between G. vaginalis 
and the occurrence of BV sign on mice, such as the presence of sialidase activity and thus exfoliated 
epithelial cells with adherent bacteria (49). Unfortunately, this animal model showed absence of 
histological inflammation or any other host-specific factor. Similar problems occur in in vitro models that 
fail to mimic several factors associated with BV infection, such as local cytokine production and 
proinflammatory immune response of the human host (50). As is, due to the absence of reliable animal 
models for multispecies BV development studies, we still need to rely in the best possible accurate in vitro 
models, in order to evaluate the virulence capacities of G. vaginalis and other BV-associated anaerobes. 
 
Conclusions and future directions  
 Even taking in consideration the limitations in the study of multispecies biofilms in BV, current 
data suggest that certain anaerobic species can cooperate and establish differently types of bacterial 
relationships with G. vaginalis biofilms, during BV development. G. vaginalis appears to be the most 
virulent BV-associated anaerobe, demonstrating greater adherence to vaginal cells, cytotoxicity and 
biofilm-producing capacity. These virulence factors suggest that G. vaginalis plays a key role in BV 
biofilms development. Its great ability to adhere to vaginal epithelial cells and produce a biofilm may help 
to initiate BV establishment as well as facilitate the adherence and growth of other BV-associated 
anaerobes. Increasing evidence makes it plausible that G. vaginalis acts as the primary colonizer in the 
vaginal epithelium and eventually establish symbiotic relationships in the presence of potential 
intermediate anaerobes. The role of this secondary species is the question that now needs to be 
addressed in future research into G. vaginalis biofilms analysis. Also, further comparative genomic 
studies should be performed in G. vaginalis isolated from BV or from healthy woman, for a better 
clarification of their interactions with other bacterial species and properties against human host-specific 
factors. These complex and diverse bacterial-host interactions may explain BV symptoms, such as the 
sloughing of clue cells and vaginal inflammatory immune responses. In future studies, the transcriptomic 
and metabolic analysis of the interactions between BV-associated anaerobes, such as co-aggregation, 
co-adherence to vaginal cells and growth in a multispecies biofilm, could be the key to better understand 
BV etiology.  
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